Published in Am J Pathol on May 01, 1991
C3a mediates epithelial-to-mesenchymal transition in proteinuric nephropathy. J Am Soc Nephrol (2009) 1.85
Urinary excretion of fatty acid-binding protein reflects stress overload on the proximal tubules. Am J Pathol (2004) 1.56
Albumin stimulates interleukin-8 expression in proximal tubular epithelial cells in vitro and in vivo. J Clin Invest (2003) 1.51
Activation of adenosine 2A receptors preserves structure and function of podocytes. J Am Soc Nephrol (2007) 1.12
Renal extracellular matrix accumulation in acute puromycin aminonucleoside nephrosis in rats. Am J Pathol (1992) 0.93
Retinoids as a potential treatment for experimental puromycin-induced nephrosis. Br J Pharmacol (2003) 0.90
CXCL10 induces the recruitment of monocyte-derived macrophages into kidney, which aggravate puromycin aminonucleoside nephrosis. Clin Exp Immunol (2015) 0.89
Protective effects of L-type fatty acid-binding protein (L-FABP) in proximal tubular cells against glomerular injury in anti-GBM antibody-mediated glomerulonephritis. Nephrol Dial Transplant (2011) 0.86
Passive dual immunization against tumour necrosis factor-alpha (TNF-alpha) and IL-1 beta maximally ameliorates acute aminonucleoside nephrosis. Clin Exp Immunol (1995) 0.81
Akt recruits Dab2 to albumin endocytosis in the proximal tubule. Am J Physiol Renal Physiol (2014) 0.78
Proteinuria and progression of glomerular diseases. Pediatr Nephrol (2012) 0.78
Regulation of the costimulator B7, not class II major histocompatibility complex, restricts the ability of murine kidney tubule cells to stimulate CD4+ T cells. J Clin Invest (1994) 0.77
Plasma potassium, diuretic use and risk of developing chronic kidney disease in a predominantly White population. PLoS One (2017) 0.75
Detection of renal brush border membrane enzymes for evaluation of renal injury in neonatal scleredema. Pak J Med Sci (2015) 0.75
Integrins: a family of cell surface receptors. Cell (1987) 21.14
Some statistical methods useful in circulation research. Circ Res (1980) 11.88
Secretory products of macrophages. J Clin Invest (1987) 10.33
The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology (1985) 7.77
Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci U S A (1987) 6.43
Two subsets of rat T lymphocytes defined with monoclonal antibodies. Eur J Immunol (1980) 5.98
Human monocyte chemoattractant protein-1 (MCP-1). Immunol Today (1990) 3.31
Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest (1986) 2.96
Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest (1986) 2.91
The roles of host and donor cells in the rejection of skin allografts by T cell-deprived rats injected with syngeneic T cells. Eur J Immunol (1982) 2.48
Renal filtration, transport, and metabolism of low-molecular-weight proteins: a review. Kidney Int (1979) 2.45
A new role for complement in experimental membranous nephropathy in rats. J Clin Invest (1980) 2.11
Alveolar macrophage replication. One mechanism for the expansion of the mononuclear phagocyte population in the chronically inflamed lung. J Clin Invest (1984) 1.68
Pathogenesis and therapy of interstitial nephritis. Kidney Int (1989) 1.64
Leukocyte analysis using monoclonal antibodies in human glomerulonephritis. Kidney Int (1987) 1.60
Differential effects of the various isoforms of platelet-derived growth factor on chemotaxis of fibroblasts, monocytes, and granulocytes. J Clin Invest (1990) 1.59
Prevention of diabetes in BioBreeding/Worcester rats with monoclonal antibodies that recognize T lymphocytes or natural killer cells. J Exp Med (1986) 1.57
Coexpression of keratin and vimentin in damaged and regenerating tubular epithelia of the kidney. Am J Pathol (1987) 1.53
The importance of the pre-irradiation breathing times of oxygen and carbogen (5% CO2: 95% O2) on the in vivo radiation response of a murine sarcoma. Int J Radiat Oncol Biol Phys (1978) 1.49
Interstitial nephritis induced by protein-overload proteinuria. Am J Pathol (1989) 1.44
Molecular nature of the W3/25 and MRC OX-8 marker antigens for rat T lymphocytes: comparisons with mouse and human antigens. Eur J Immunol (1983) 1.28
Membrane attack complex of complement as a pathologic mediator. Lab Invest (1983) 1.21
In vivo treatment of rats with monoclonal anti-T-cell antibodies. Immunohistochemical and functional analysis in normal rats and in experimental allergic neuritis. Scand J Immunol (1985) 1.20
A role for oxygen free radicals in aminonucleoside nephrosis. Kidney Int (1986) 1.18
The distribution of the CR3 receptor on human cells and tissue as revealed by a monoclonal antibody. Clin Immunol Immunopathol (1984) 1.17
Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? Kidney Int (1990) 1.17
Differential nephrotoxicity of low molecular weight proteins including Bence Jones proteins in the perfused rat nephron in vivo. J Clin Invest (1988) 1.12
Differing regulation and function of ICAM-1 and class II antigens on renal tubular cells. Kidney Int (1990) 1.12
Renal handling of low molecular weight proteins. I. L-Chain metabolism in experimental renal disease. J Clin Invest (1971) 1.12
Tubulo-interstitial lesions mediate renal damage in adriamycin glomerulopathy. Kidney Int (1986) 1.10
Characterization of inflammatory cells in autoimmune tubulointerstitial nephritis in rats. Kidney Int (1983) 1.08
Increased glomerular thromboxane synthesis as a possible cause of proteinuria in experimental nephrosis. J Clin Invest (1985) 1.08
Separation and isolation of rat natural killer (NK) cells from T cells with monoclonal antibodies. J Immunol (1984) 1.06
Effects of the aminonucleoside of puromycin on glomerular epithelial cells in vitro. Am J Pathol (1985) 1.06
Acute tubulointerstitial nephritis associated with aminonucleoside nephrosis. Kidney Int (1988) 1.06
Enalapril and low protein reverse chronic puromycin aminonucleoside nephropathy. Kidney Int (1990) 1.05
Mechanisms underlying transition from acute glomerular injury to late glomerular sclerosis in a rat model of nephrotic syndrome. J Clin Invest (1988) 1.03
Evidence that rat renal allografts are rejected by cytotoxic T cells and not by nonspecific effectors. Transplantation (1985) 1.02
Essential fatty acid deficiency depletes rat glomeruli of resident macrophages and inhibits angiotensin II-induced eicosanoid synthesis. J Clin Invest (1987) 1.02
Intracellular pathways of renal reabsorption of lysozyme. Am J Physiol (1971) 1.02
Proteinuria induced by sodium maleate in rats: effects on ultrastructure and protein handling in renal proximal tubule. Kidney Int (1980) 0.98
Identification of lymphohemopoietic cells in the kidneys of normal rats. Am J Pathol (1986) 0.98
Irreversible tubulointerstitial damage associated with chronic aminonucleoside nephrosis. Amelioration by angiotensin I converting enzyme inhibition. Am J Pathol (1990) 0.98
Adriamycin-induced glomerulosclerosis in the rat. Am J Kidney Dis (1986) 0.96
Essential fatty acid deficiency ameliorates acute renal dysfunction in the rat after the administration of the aminonucleoside of puromycin. J Clin Invest (1990) 0.93
Inhibition of glomerular visceral epithelial cell endocytosis during nephrosis induced by puromycin aminonucleoside. Lab Invest (1984) 0.92
Tubulointerstitial renal disease in systemic lupus erythematosus. Arch Intern Med (1985) 0.89
Low molecular weight proteinuria exacerbates experimental ischemic renal injury. Lab Invest (1987) 0.86
Cathepsin B and L in nephron segments of rats with puromycin aminonucleoside nephrosis. Kidney Int (1987) 0.85
Generation of cytotoxic T cells in the rat mixed lymphocyte reaction is blocked by monoclonal antibody MRC OX-8. Immunology (1984) 0.85
Effects of dietary interventions on glomerular pathophysiology. Am J Physiol (1990) 0.85
Failure of angiotensin converting enzyme inhibition to affect the course of chronic puromycin aminonucleoside nephropathy. Am J Pathol (1987) 0.84
In vitro alternative pathway activation of complement by the brush border of proximal tubules of normal rat kidney. J Immunol (1982) 0.83
Dietary protein intake modulates glomerular eicosanoid production in the rat. Am J Physiol (1989) 0.83
A comparison of the effects of converting-enzyme inhibition and protein restriction in experimental nephrosis. Lab Invest (1988) 0.82
Focal glomerular lesions in glomerulonephritis may be secondary to tubulointerstitial damage. Am J Kidney Dis (1988) 0.80
The effect of captopril on urinary protein excretion in puromycin aminonucleoside nephrosis in rats. Pediatr Res (1985) 0.80
Mechanisms underlying the anti-inflammatory effects of essential fatty acid deficiency in experimental glomerulonephritis. Inhibited release of a monocyte chemoattractant by glomeruli. J Immunol (1990) 0.78
Depletion of resident glomerular macrophages by essential fatty acid deficiency protects against glomerulonephritis. Adv Prostaglandin Thromboxane Leukot Res (1989) 0.78
Lipoxygenase products mediate the attachment of rat macrophages to glomeruli in vitro. Kidney Int (1985) 0.78
Dietary protein restriction and renal injury in the spontaneously hypertensive rat. Am J Physiol (1989) 0.78
Effect of captopril on chronic puromycin aminonucleoside nephrosis in rats. Res Commun Chem Pathol Pharmacol (1986) 0.76
Proteinuria and progression of renal failure in patients on a low-protein diet. Nephron (1989) 0.76
Renal mononuclear inflammatory cell populations in membranous glomerulonephritis: a fine-needle aspiration biopsy study. Clin Nephrol (1987) 0.76
Manipulation of the acute inflammatory response by dietary polyunsaturated fatty acid modulation. J Immunol (1990) 0.76
Stable analogs of prostaglandins E1 and F2 alpha ameliorate the proteinuria of aminonucleoside-of-puromycin nephrosis in Lewis rats. Am J Pathol (1987) 0.76
Comprehensive geriatric assessment: a meta-analysis of controlled trials. Lancet (1993) 8.39
The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells. Cancer Res (2001) 6.93
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease. Neurology (2009) 5.94
Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor. Science (1990) 5.49
Air pollution and incidence of cardiac arrhythmia. Epidemiology (2000) 4.96
Benefit of cervical screening at different ages: evidence from the UK audit of screening histories. Br J Cancer (2003) 4.14
Estimation of the number of sex alleles and queen matings from diploid male frequencies in a population of Apis mellifera. Genetics (1977) 3.98
The learning curve for laparoscopic colorectal surgery. Preliminary results from a prospective analysis of 1194 laparoscopic-assisted colectomies. Arch Surg (1997) 3.57
Effect of screening on cervical cancer mortality in England and Wales: analysis of trends with an age period cohort model. BMJ (1999) 3.50
A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma. Br J Haematol (2004) 3.49
Evolution of Escherichia coli during growth in a constant environment. Genetics (1987) 3.44
NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide. Proc Natl Acad Sci U S A (1990) 3.28
Eya1-deficient mice lack ears and kidneys and show abnormal apoptosis of organ primordia. Nat Genet (1999) 3.24
Microbial evolution in a simple unstructured environment: genetic differentiation in Escherichia coli. Genetics (1994) 3.19
Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J (Clin Res Ed) (1986) 3.14
Coronary vasospasm induced by subcutaneous sumatriptan. BMJ (1992) 3.13
RNA recognition by a Staufen double-stranded RNA-binding domain. EMBO J (2000) 3.12
Frequency of fixation of adaptive mutations is higher in evolving diploid than haploid yeast populations. Nature (1983) 3.03
Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem Biophys Res Commun (1990) 2.77
The Arabidopsis NPR1/NIM1 protein enhances the DNA binding activity of a subgroup of the TGA family of bZIP transcription factors. Plant Cell (2000) 2.76
Repeated evolution of an acetate-crossfeeding polymorphism in long-term populations of Escherichia coli. Mol Biol Evol (1998) 2.69
Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-kappa B, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma. Clin Cancer Res (2001) 2.65
Detection of amplified oncogenes by differential polymerase chain reaction. Oncogene (1989) 2.63
Polycystic ovaries--a common finding in normal women. Lancet (1988) 2.58
A novel dipyridodiazepinone inhibitor of HIV-1 reverse transcriptase acts through a nonsubstrate binding site. Biochemistry (1991) 2.57
Pattern of malformations in the children of women treated with carbamazepine during pregnancy. N Engl J Med (1989) 2.56
Evidence for high-energy extraterrestrial neutrinos at the IceCube detector. Science (2013) 2.56
ras oncogene activation and occupational exposures in acute myeloid leukemia. J Natl Cancer Inst (1992) 2.54
Determinants of patient satisfaction and willingness to return with emergency care. Ann Emerg Med (2000) 2.49
Admixture studies and the detection of selection. Science (1973) 2.41
Relative fitness can decrease in evolving asexual populations of S. cerevisiae. Nature (2006) 2.40
Complications of hydroxyapatite orbital implants. A review of 100 consecutive cases and a comparison of Dexon mesh (polyglycolic acid) with scleral wrapping. Ophthalmology (1997) 2.39
Paraoxonase cluster polymorphisms are associated with sporadic ALS. Neurology (2006) 2.38
Arm edema in breast cancer patients. J Natl Cancer Inst (2001) 2.35
A systematic review of the role of human papillomavirus testing within a cervical screening programme. Health Technol Assess (1999) 2.32
Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome. BMJ (1988) 2.29
Intermittent versus continuous renal replacement therapy for acute renal failure in adults. Cochrane Database Syst Rev (2007) 2.26
Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: implications for systemic nuclear factor-kappaB inhibition. Cancer Res (2001) 2.18
Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone. Lancet (1986) 2.14
Case-mix adjustment of the National CAHPS benchmarking data 1.0: a violation of model assumptions? Health Serv Res (2001) 2.10
Screening for vertebral osteoporosis using individual risk factors. The Multicentre Vertebral Fracture Study Group. Osteoporos Int (1991) 2.07
Fas ligand, Bcl-2, granulocyte colony-stimulating factor, and p38 mitogen-activated protein kinase: Regulators of distinct cell death and survival pathways in granulocytes. J Exp Med (2000) 2.07
Frequency-Dependent Selection for Plasmid-Containing Cells of ESCHERICHIA COLI. Genetics (1979) 2.07
Changing rates of adenocarcinoma and adenosquamous carcinoma of the cervix in England. Lancet (2001) 2.05
Proteasome inhibition measurements: clinical application. Clin Chem (2000) 2.04
Ovulatory disorders in women with polycystic ovary syndrome. Clin Obstet Gynaecol (1985) 2.00
First observation of PeV-energy neutrinos with IceCube. Phys Rev Lett (2013) 2.00
Estimation of phylogenetic relationships from DNA restriction patterns and selection of endonuclease cleavage sites. Proc Natl Acad Sci U S A (1982) 1.98
Genetic evidence that Neisseria gonorrhoeae produces specific receptors for transferrin and lactoferrin. J Bacteriol (1990) 1.94
The proteasome inhibitor PS-341 in cancer therapy. Clin Cancer Res (1999) 1.94
Characterization of the binding site for nevirapine (BI-RG-587), a nonnucleoside inhibitor of human immunodeficiency virus type-1 reverse transcriptase. J Biol Chem (1991) 1.90
Distinct roles of two conserved Staufen domains in oskar mRNA localization and translation. EMBO J (2000) 1.87
The maintenance of Plasmid-containing organisms in populations of Escherichia coli. J Gen Microbiol (1981) 1.85
Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect. Lancet (1996) 1.81
Polymerase chain reaction based assay to detect allelic loss in human DNA: loss of beta-interferon gene in chronic myelogenous leukemia. Nucleic Acids Res (1990) 1.76
Laparoscopic complications in markedly obese urologic patients (a multi-institutional review) Urology (1996) 1.75
Role of the proteasome and NF-kappaB in streptococcal cell wall-induced polyarthritis. Proc Natl Acad Sci U S A (1998) 1.69
Enhancement of radiosensitivity by proteasome inhibition: implications for a role of NF-kappaB. Int J Radiat Oncol Biol Phys (2001) 1.67
Continuous ambulatory peritoneal dialysis versus automated peritoneal dialysis for end-stage renal disease. Cochrane Database Syst Rev (2007) 1.67
Overproduction of three genes leads to camphor resistance and chromosome condensation in Escherichia coli. Genetics (1996) 1.64
Fibromyalgia: a risk factor for osteoporosis. J Rheumatol (1999) 1.63
Nonoperative management of posterior tibial tendon dysfunction. Foot Ankle Int (1996) 1.61
Evaluation of outpatient geriatric assessment: a randomized multi-site trial. J Am Geriatr Soc (1995) 1.58
Molecular and imaging correlates of the fragile X-associated tremor/ataxia syndrome. Neurology (2006) 1.55
Cysteine usage increases the need for acetate in neonates who receive total parenteral nutrition. Am J Clin Nutr (1991) 1.53
Proteasome inhibition with bortezomib (PS-341): a phase I study with pharmacodynamic end points using a day 1 and day 4 schedule in a 14-day cycle. J Clin Oncol (2005) 1.50
Pharmacological effects of SB 220025, a selective inhibitor of P38 mitogen-activated protein kinase, in angiogenesis and chronic inflammatory disease models. J Pharmacol Exp Ther (1998) 1.46
A community-level HIV prevention intervention for inner-city women: results of the women and infants demonstration projects. Am J Public Health (2000) 1.46
Ultrasound demonstration of increased frequency of functional ovarian cysts in women using progestogen-only oral contraception. Br J Obstet Gynaecol (1985) 1.44
Migration of cardiac neural crest cells in Splotch embryos. Development (2000) 1.43
Large-volume paracentesis in the management of ascites in children. J Pediatr Gastroenterol Nutr (2001) 1.42
Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features. J Clin Endocrinol Metab (2006) 1.41
Juvenile spring eruption of the ears: a probable variant of polymorphic light eruption. Br J Dermatol (1991) 1.40
Gene array of VHL mutation and hypoxia shows novel hypoxia-induced genes and that cyclin D1 is a VHL target gene. Br J Cancer (2004) 1.39
Wnt pathway regulation in chronic renal allograft damage. Am J Transplant (2009) 1.39
The Wake-up Call. West J Med (1993) 1.39
Incidence of activating ras oncogene mutations associated with primary and metastatic human breast cancer. Cancer Res (1989) 1.39
Orientation of histopathology specimens. Br J Oral Maxillofac Surg (2004) 1.38
ATP-induced killing of virulent Mycobacterium tuberculosis within human macrophages requires phospholipase D. J Immunol (2000) 1.38
Defining constant versus variable phenotypic features of women with polycystic ovary syndrome using different ethnic groups and populations. J Clin Endocrinol Metab (2006) 1.38
Event-related potentials in schizophrenia: their biological and clinical correlates and a new model of schizophrenic pathophysiology. Schizophr Res (1991) 1.38
The use of traditional, complementary and alternative medicine in Sri Lankan cancer care: results from a survey of 500 cancer patients. Public Health (2010) 1.36
Identification of vertebral fractures: an update. Osteoporos Int (2005) 1.34
Fitness effects of Ty transposition in Saccharomyces cerevisiae. Genetics (1992) 1.33
Estimation of expected number of rare alleles of a locus and calculation of mutation rate. Proc Natl Acad Sci U S A (1978) 1.32
Too much of a good thing: retinoic acid as an endogenous regulator of neural differentiation and exogenous teratogen. Eur J Neurosci (2003) 1.32
The relationship between enzyme activity, cell geometry, and fitness in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1975) 1.31
Detection of Epstein-Barr virus genomes in Hodgkin's disease: relation to age. J Clin Pathol (1991) 1.29
Population studies in microorganisms. I. Evolution of diploidy in Saccharomyces cerevisiae. Genetics (1974) 1.28
Physiological characterization of adaptive clones in evolving populations of the yeast, Saccharomyces cerevisiae. Genetics (1985) 1.28
Association between amputation, arthritis and osteopenia in British male war veterans with major lower limb amputations. Clin Rehabil (1998) 1.28
Induction of ovulation with pulsatile luteinising hormone releasing hormone. Br Med J (Clin Res Ed) (1984) 1.26
Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by the dipyridodiazepinone BI-RG-587. J Infect Dis (1991) 1.26
Structure of evolving populations of Saccharomyces cerevisiae: adaptive changes are frequently associated with sequence alterations involving mobile elements belonging to the Ty family. Proc Natl Acad Sci U S A (1986) 1.26
Tetracycline-resistant gonococci in UK. Lancet (1988) 1.26
The response of general practitioners to the threat of violence in their practices: results from a qualitative study. Fam Pract (2006) 1.25
Mechanisms of immune lysis of the red cells in hereditary erythroblastic multinuclearity with a positive acidified serum test and paroxysmal nocturnal hemoglobinuria. J Clin Invest (1974) 1.24
Lack of multicellular drug resistance observed in human ovarian and prostate carcinoma treated with the proteasome inhibitor PS-341. Clin Cancer Res (2000) 1.24
New insights into proteasome function: from archaebacteria to drug development. Chem Biol (1995) 1.23
26S proteasome inhibition induces apoptosis and limits growth of human pancreatic cancer. J Cell Biochem (2001) 1.23